This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Special RNA shown to suppress the formation of breast cancer cells

Special RNA suppresses the formation of breast cancer cells
Credit: Cell Reports (2024). DOI: 10.1016/j.celrep.2023.113644

Breast cancer is the most common cancer in women. The development of breast cancer often originates from epithelial cells in the mammary gland—the very cells that specialize in milk production during and after pregnancy.

A team of researchers from Friedrich Schiller University Jena (Germany), the university in Shenzhen (China) and Jena University Hospital (Germany) has taken a closer look at this specialization process and deciphered a that also appears to play an important role in cancer development.

It may be possible to develop new diagnostic procedures and treatment methods for breast cancer based on these research findings now published in Cell Reports.

Cell differentiation, i.e., cell specialization, is the process by which cells take on different tasks. During lactogenesis—the process triggered by hormones that enables the mammary glands to produce milk—the relevant cells multiply first. The proteins required for this are produced by the ribosomes. A fundamental building block of ribosomes is ribosomal RNA, or rRNA for short.

If more proteins are required, the demand for rRNA also increases, and its synthesis in the is ramped up accordingly. At the end of lactogenesis, the specialized cells stop growing and reduce rRNA synthesis again. This takes place at the epigenetic level, which means that it is not the DNA itself that changes, but its packaging, for which another type of RNA is responsible.

"We've found out that a long, non-coding RNA called PAPAS, which I had discovered a few years ago, acts on the packaging of the DNA and reduces rRNA production," explains Dr. Holger Bierhoff, who is leading the project at the University of Jena.

"More precisely, PAPAS influences access to the active regions of the DNA and determines whether these are copied into RNA or not. If a lot of ribosomes and proteins, and thus a lot of rRNA are needed, the synthesis of PAPAS is reduced. If this process is to be stopped, the PAPAS level is increased."

The experts in Jena also discovered that PAPAS not only plays an important role in , but also in specialization. "When we switched off PAPAS through gene manipulation in cells, we observed that the development into milk-producing cells no longer functioned properly," says Bierhoff.

High PAPAS level, low tumor growth

Synthesis of rRNA is also increased in cancer cells, as they multiply rapidly and require a lot of proteins—and accordingly a lot of ribosomes. "We therefore asked ourselves whether the regulatory mechanism we observed also plays a role in the development of breast cancer. The answer is clearly yes," explains cell biologist Bierhoff.

"When we reduced PAPAS synthesis and switched off cell specialization, we observed that the cells developed the characteristics of cancer cells." In contrast, the researchers showed both in cell cultures and in mice that a high PAPAS level reduces tumor growth as well as the spread of metastases.

But how do cancer cells manage to switch off PAPAS production and thus boost rRNA synthesis? "We have also found a mechanism for this," explains Bierhoff. "Production of PAPAS requires a molecular signal at the start of the PAPAS gene. This signaling structure is regulated by particular proteins, which can resolve or block the structure. We've observed that the production of these proteins is particularly high in cells. The more aggressive the tumor, the more of them are present."

For Holger Bierhoff, the research results are promising in two respects. "First, we see that PAPAS can be an interesting marker for assessing the aggressiveness of a breast tumor. This information could potentially be used as a diagnostic tool," he says. "Second, we're already working on developing an RNA therapy for cancer treatment. We know the mechanism by which PAPAS regulates rRNA synthesis and we know which region of the RNA is required for this.

"Now, the idea is to produce this part of PAPAS artificially, package it in nanoparticles, and introduce it into the , thereby restoring its function. In this way, we would reduce rRNA , which the cancer needs to proliferate." This strategy would be similar to mRNA vaccines, like the one against COVID-19, however, here a regulatory RNA instead of protein-coding RNA would be applied.

More information: Sijia Ren et al, PAPAS promotes differentiation of mammary epithelial cells and suppresses breast carcinogenesis, Cell Reports (2024). DOI: 10.1016/j.celrep.2023.113644

Journal information: Cell Reports
Citation: Special RNA shown to suppress the formation of breast cancer cells (2024, January 16) retrieved 23 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Researchers reveal composition and regulatory mechanism of the nucleolar vacuole in C. elegans


Feedback to editors